Gut microbiota: next frontier in understanding human health and development of biotherapeutics
Satya Prakash, Laetitia Rodes, Michael Coussa-Charley, Catherine Tomaro-DuchesneauBiomedical Technology and Cell Therapy Research Laboratory, Department of Biomedical Engineering and Artificial Cells and Organs Research Centre, Faculty of Medicine, McGill University, Montreal, Quebec, CanadaAbstract...
Guardado en:
Autores principales: | Prakash S, Rodes L, Coussa-Charley M, Tomaro-Duchesneau C |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2011
|
Materias: | |
Acceso en línea: | https://doaj.org/article/cb2e6987a8c0444dbdbe0c88bd8f5481 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Potentials and limitations of microorganisms as renal failure biotherapeutics
por: Poonam Jain, et al.
Publicado: (2009) -
Development and characterization of chitosan-PEG-TAT nanoparticles for the intracellular delivery of siRNA
por: Malhotra M, et al.
Publicado: (2013) -
Colon-targeted delivery of live bacterial cell biotherapeutics including microencapsulated live bacterial cells
por: Satya Prakash, et al.
Publicado: (2008) -
How will our understanding of human development evolve over the next 10 years
por: Ali H. Brivanlou, et al.
Publicado: (2021) - Frontiers in Health Informatics